KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to -$14.5 million.

  • Jazz Pharmaceuticals' Other Working Capital Changes fell 60.47% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year decrease of 109.68%. This contributed to the annual value of -$14.5 million for FY2024, which is 111.52% down from last year.
  • According to the latest figures from FY2024, Jazz Pharmaceuticals' Other Working Capital Changes is -$14.5 million, which was down 111.52% from $126.2 million recorded in FY2023.
  • In the past 5 years, Jazz Pharmaceuticals' Other Working Capital Changes registered a high of $126.2 million during FY2023, and its lowest value of -$35.8 million during FY2022.
  • Its 3-year average for Other Working Capital Changes is $25.3 million, with a median of -$14.5 million in 2024.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Other Working Capital Changes tumbled by 142.95% in 2022 and then soared by 452.57% in 2023.
  • Over the past 5 years, Jazz Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $98.0 million in 2020, then dropped by 15.02% to $83.3 million in 2021, then tumbled by 142.95% to -$35.8 million in 2022, then spiked by 452.57% to $126.2 million in 2023, then crashed by 111.52% to -$14.5 million in 2024.